The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer’s Disease
Open accessAbstract
P38 mitogen-activated protein kinase (MAPK) is a crucial target for chronic inflammatory diseases. Alzheimer’s disease (AD) is characterized by the presence of amyloid plaques and neurofibrillary tangles in the brain, as well as neurodegeneration, and there is no known cure. Recent studies on the underlying biology of AD in cellular and animal models have indicated that p38 MAPK is capable of orchestrating diverse events related to AD, such as tau phosphorylation, neurotoxicity, neuroinflammation and synaptic dysfunction. Thus, the inhibition of p38 MAPK is considered a promising strategy for the treatment of AD. In this review, we summarize recent advances in the targeting of p38 MAPK as a potential strategy for the treatment of AD and envision possibilities of p38 MAPK inhibitors as a fundamental therapeutics for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“In AD, NFTs first appear in the transentorhinal cortex and spread to the hippocampus and, eventually, the cortex [41].”
BackgroundThe global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Immune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134
Borst, O., Walker, B., Münzer, P., Russo, A., Schmid, E., Faggio, C., Bigalke, B., Laufer, S., Gawaz, M., & Lang, F. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350110 · Cited by 1,860
Mitogen-activated protein kinases in innate immunity
Arthur, J. S. C., & Ley, S. C. (2013) · Nature Reviews Immunology · doi:10.1038/nri3495 · Cited by 1,855
A review on Alzheimer's disease pathophysiology and its management: an update
Kumar, A., Singh, A., & Ekavali (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.004 · Cited by 1,578
p38 MAP-Kinases pathway regulation, function and role in human diseases
Cuenda, A., & Rousseau, S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.03.010 · Cited by 1,400
McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
Alzheimer’s disease: Clinical trials and drug development
Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217
p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases
Kumar, S., Boehm, J., & Lee, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1177 · Cited by 1,197
Self-citationSystemic inflammation and disease progression in Alzheimer disease
Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139 · cited 1×
“Accumulating evidence indicates that neuroinflammatory processes also directly contribute to AD pathogenesis, including the activation of astrocytes and microglia, which can increase the expression of cytokines or chemokines [45].”
BackgroundMicroglial priming in neurodegenerative disease
Perry, V. H., & Holmes, C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.38 · Cited by 1,127
AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
Phosphorylation affects the ability of tau protein to promote microtubule assembly.
Lindwall, G., & Cole, R. D. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42989-9 · Cited by 901
Morris, M., Maeda, S., Vossel, K., & Mucke, L. (2011) · Neuron · doi:10.1016/j.neuron.2011.04.009 · Cited by 899
The genetic landscape of Alzheimer disease: clinical implications and perspectives
Van Cauwenberghe, C., Van Broeckhoven, C., & Sleegers, K. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.117 · Cited by 863
Burns, A., & Iliffe, S. (2009) · BMJ · doi:10.1136/bmj.b158 · Cited by 859
The role of inflammation in Alzheimer’s disease
Tuppo, E. E., & Arias, H. R. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.009 · Cited by 734
Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs
Forman, M. S., Trojanowski, J. Q., & Lee, V. M.-Y. (2004) · Nature Medicine · doi:10.1038/nm1113 · Cited by 715
Bhat, N. R., Zhang, P., Lee, J. C., & Hogan, E. L. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01633.1998 · Cited by 713
Self-citationLi, S., Jin, M., Koeglsperger, T., Shepardson, N. E., Shankar, G. M., & Selkoe, D. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0203-11.2011 · Cited by 671
Post-translational modifications of tau protein: Implications for Alzheimer's disease
Martin, L., Latypova, X., & Terro, F. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.023 · Cited by 641
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583
Um, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Takahashi, H., Kerrisk, M. E., Vortmeyer, A., Wisniewski, T., Koleske, A. J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.036 · Cited by 572
Li, Y., Liu, L., Barger, S. W., & Griffin, W. S. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01605.2003 · Cited by 563
Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons
Caceres, A., & Kosik, K. S. (1990) · Nature · doi:10.1038/343461a0 · Cited by 559
Alzheimer's disease: synaptic dysfunction and Aβ
Shankar, G. M., & Walsh, D. M. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-48 · Cited by 486
Deciphering the mechanism underlying late-onset Alzheimer disease
Krstic, D., & Knuesel, I. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.236 · Cited by 457
Inflammatory markers and the risk of Alzheimer disease: The Framingham Study
Tan, Z. S., Beiser, A. S., Vasan, R. S., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Au, R., Kiel, D. P., Wolf, P. A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000263217.36439.da · Cited by 440
Synaptic Impairment in Alzheimer’s Disease: A Dysregulated Symphony
Forner, S., Baglietto-Vargas, D., Martini, A. C., Trujillo-Estrada, L., & LaFerla, F. M. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.04.002 · Cited by 430
The amyloid cascade hypothesis: are we poised for success or failure?
Karran, E., & De Strooper, B. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13632 · Cited by 402
Ghosh, S., Wu, M. D., Shaftel, S. S., Kyrkanides, S., LaFerla, F. M., Olschowka, J. A., & O'Banion, M. K. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4361-12.2013 · Cited by 390
A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s disease
Scharf, S., Mander, A., Ugoni, A., Vajda, F., & Christophidis, N. (1999) · Neurology · doi:10.1212/wnl.53.1.197 · Cited by 390
A randomized controlled trial of prednisone in Alzheimer’s disease
Koch, H. J., & Szecsey, A. (2000) · Neurology · doi:10.1212/wnl.55.7.1067 · Cited by 384
Zhu, X., Rottkamp, C. A., Boux, H., Takeda, A., Perry, G., & Smith, M. A. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.10.880 · Cited by 378
p38 Kinase Is Activated in the Alzheimer's Disease Brain
Hensley, K., Floyd, R. A., Zheng, N., Nael, R., Robinson, K. A., Nguyen, X., Pye, Q. N., Stewart, C. A., Geddes, J., Markesbery, W. R., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722053.x · Cited by 373
Targeting p38 MAPK pathway for the treatment of Alzheimer's disease
Munoz, L., & Ammit, A. J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.010 · Cited by 369
Plaque formation and the intraneuronal accumulation of β‐amyloid in Alzheimer's disease
Takahashi, R. H., Nagao, T., & Gouras, G. K. (2017) · Pathology International · doi:10.1111/pin.12520 · Cited by 346
Molecular Cloning and Characterization of a Novel p38 Mitogen-activated Protein Kinase
Wang, X. S., Diener, K., Manthey, C. L., Wang, S.-W., Rosenzweig, B., Bray, J., Delaney, J., Cole, C. N., Chan-Hui, P.-Y., Mantlo, N., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23668 · Cited by 330
Microtubule-associated protein tau is essential for long-term depression in the hippocampus
Kimura, T., Whitcomb, D. J., Jo, J., Regan, P., Piers, T., Heo, S., Brown, C., Hashikawa, T., Murayama, M., Seok, H., et al. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0144 · Cited by 307
Da Silva, J., Pierrat, B., Mary, J.-L., & Lesslauer, W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28373 · Cited by 301
Saha, R. N., Jana, M., & Pahan, K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.7101 · Cited by 289
Bachstetter, A. D., Xing, B., de Almeida, L., Dimayuga, E. R., Watterson, D. M., & Van Eldik, L. J. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-79 · Cited by 282
Potent amyloidogenicity and pathogenicity of Aβ43
Saito, T., Suemoto, T., Brouwers, N., Sleegers, K., Funamoto, S., Mihira, N., Matsuba, Y., Yamada, K., Nilsson, P., Takano, J., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2858 · Cited by 280
Mondragón-Rodríguez, S., Trillaud-Doppia, E., Dudilot, A., Bourgeois, C., Lauzon, M., Leclerc, N., & Boehm, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.401240 · Cited by 272
Giraldo, E., Lloret, A., Fuchsberger, T., & Viña, J. (2014) · Redox Biology · doi:10.1016/j.redox.2014.03.002 · Cited by 268
Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s mice
Ittner, A., Chua, S. W., Bertz, J., Volkerling, A., van der Hoven, J., Gladbach, A., Przybyla, M., Bi, M., van Hummel, A., Stevens, C. H., et al. (2016) · Science · doi:10.1126/science.aah6205 · Cited by 263
Interleukin-1 mediates Alzheimer and Lewy body pathologies
Griffin, W. S. T., Liu, L., Li, Y., Mrak, R. E., & Barger, S. W. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-5 · Cited by 262
Mitochondria dysfunction of Alzheimer's disease cybrids enhances Aβ toxicity
Cardoso, S. M., Santana, I., Swerdlow, R. H., & Oliveira, C. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02438.x · Cited by 261
Protein phosphorylation in neurodegeneration: friend or foe?
Tenreiro, S., Eckermann, K., & Outeiro, T. F. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00042 · Cited by 252
McDonald, D. R., Bamberger, M. E., Combs, C. K., & Landreth, G. E. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04451.1998 · Cited by 252
Calkins, M. J., & Reddy, P. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.01.007 · Cited by 244
Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1β production
Kim, S. H., Smith, C. J., & Van Eldik, L. J. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00126-x · Cited by 235
Cohen, S. B., Cheng, T., Chindalore, V., Damjanov, N., Burgos‐Vargas, R., DeLora, P., Zimany, K., Travers, H., & Caulfield, J. P. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24266 · Cited by 231
Munoz, L., Ranaivo, H. R., Roy, S. M., Hu, W., Craft, J. M., McNamara, L. K., Chico, L. W., Van Eldik, L. J., & Watterson, D. M. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-21 · Cited by 224
Lee, M. R., & Dominguez, C. (2005) · Current Medicinal Chemistry · doi:10.2174/092986705774462914 · Cited by 223
Dual MAP kinase pathways mediate opposing forms of long-term plasticity at CA3–CA1 synapses
Bolshakov, V. Y., Carboni, L., Cobb, M. H., Siegelbaum, S. A., & Belardetti, F. (2000) · Nature Neuroscience · doi:10.1038/80624 · Cited by 220
P38 MAP kinase is activated at early stages in Alzheimer's disease brain
Sun, A. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00180-8 · Cited by 219
Xuan, A., Long, D., Li, J., Ji, W., Zhang, M., Hong, L., & Liu, J. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-202 · Cited by 210
Targeting protein kinases for the development of anti-inflammatory drugs
Cohen, P. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.01.015 · Cited by 207
Tau Phosphorylation at Serine 396 Residue Is Required for Hippocampal LTD
Regan, P., Piers, T., Yi, J.-H., Kim, D.-H., Huh, S., Park, S. J., Ryu, J. H., Whitcomb, D. J., & Cho, K. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2842-14.2015 · Cited by 202
Therapeutic Protein Kinase Inhibitors
Grant, S. K. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8539-7 · Cited by 194
Kim, T. I., Lee, Y. K., Park, S. G., Choi, I. S., Ban, J. O., Park, H. K., Nam, S.-Y., Yun, Y. W., Han, S. B., Oh, K. W., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.09.008 · Cited by 192
Giovannini, M. G., Scali, C., Prosperi, C., Bellucci, A., Vannucchi, M. G., Rosi, S., Pepeu, G., & Casamenti, F. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0538 · Cited by 190
p38 MAPK-mediated Transcriptional Activation of Inducible Nitric-oxide Synthase in Glial Cells
Bhat, N. R., Feinstein, D. L., Shen, Q., & Bhat, A. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204994200 · Cited by 181
Sheng, J. G., Jones, R. A., Zhou, X. Q., McGinness, J. M., Van Eldik, L. J., Mrak, R. E., & Griffin, W. S. T. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00041-9 · Cited by 176
The interleukin‐1 signalling pathway in astrocytes: a key contributor to inflammation in the brain
Moynagh, P. N. (2005) · Journal of Anatomy · doi:10.1111/j.1469-7580.2005.00445.x · Cited by 166
MATTSON, M. P. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44401.x · Cited by 166
Pei, J.-J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., & Cowburn, R. F. (2001) · Journal of Alzheimer's Disease · doi:10.3233/jad-2001-3107 · Cited by 165
Activation of MKK6, an upstream activator of p38, in Alzheimer's disease
Zhu, X., Rottkamp, C. A., Hartzler, A., Sun, Z., Takeda, A., Boux, H., Shimohama, S., Perry, G., & Smith, M. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00597.x · Cited by 162
Clearance of Amyloid-β Peptides By Microglia and Macrophages: the Issue of What, When and Where
Lai, A. Y., & McLaurin, J. (2012) · Future Neurology · doi:10.2217/fnl.12.6 · Cited by 162
Novel strategies for inhibition of the p38 MAPK pathway
ZHANG, J., SHEN, B., & LIN, A. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.04.008 · Cited by 161
Marber, M. S., Rose, B., & Wang, Y. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.021 · Cited by 158
Mattson, M. P. (1994) · PubMed · Cited by 154
Hamilton, A., Esseltine, J. L., DeVries, R. A., Cregan, S. P., & Ferguson, S. S. G. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-40 · Cited by 151
Liu, R., Wu, C., Zhou, D., Yang, F., Tian, S., Zhang, L., Zhang, T., & Du, G. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-105 · Cited by 150
Schnöder, L., Hao, W., Qin, Y., Liu, S., Tomic, I., Liu, X., Fassbender, K. C., & Liu, Y. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.695916 · Cited by 150
Wang, H., Sun, X.-B., Xu, Y.-X., Zhao, H., Zhu, Q.-Y., & Zhu, C.-Q. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.100 · Cited by 148
Sabogal-Guáqueta, A. M., Osorio, E., & Cardona-Gómez, G. P. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.11.002 · Cited by 148
Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology
Maphis, N., Jiang, S., Xu, G., Kokiko-Cochran, O. N., Roy, S. M., Van Eldik, L. J., Watterson, D. M., Lamb, B. T., & Bhaskar, K. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0221-y · Cited by 147 · cited 2×
“In addition, p38α-specific inhibition was effective in memory recovery and ameliorating AD symptoms in in vitro/vivo models [163].”
BackgroundThe role of astrocytes in amyloid β-protein toxicity and clearance
Thal, D. R. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.04.021 · Cited by 146
Tau Therapeutic Strategies for the Treatment of Alzheimers Disease
Churcher, I. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776743057 · Cited by 144
Zhao, L., Wang, J., Wang, Y.-R., & Fa, X.-Z. (2012) · Brain Research · doi:10.1016/j.brainres.2012.11.019 · Cited by 140
Donepezil inhibits the amyloid-beta oligomer-induced microglial activation in vitro and in vivo
Kim, H. G., Moon, M., Choi, J. G., Park, G., Kim, A., Hur, J., Lee, K., & Oh, M. S. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.10.004 · Cited by 137
Cavallini, A., Brewerton, S., Bell, A., Sargent, S., Glover, S., Hardy, C., Moore, R., Calley, J., Ramachandran, D., Poidinger, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463984 · Cited by 133
Feijoo, C., Campbell, D. G., Jakes, R., Goedert, M., & Cuenda, A. (2005) · Journal of Cell Science · doi:10.1242/jcs.01655 · Cited by 133
Neuronal regulation of immune responses in the central nervous system
Tian, L., Rauvala, H., & Gahmberg, C. G. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.11.002 · Cited by 130
Novel insights for the treatment of Alzheimer's disease
Kurz, A., & Perneczky, R. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.018 · Cited by 129
Honarvar, N. M., Saedisomeolia, A., Abdolahi, M., Shayeganrad, A., Sangsari, G. T., Rad, B. H., & Muench, G. W. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0857-x · Cited by 128
Yokota, T., & Wang, Y. (2016) · Gene · doi:10.1016/j.gene.2015.09.030 · Cited by 127
Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor
Koeberle, S. C., Romir, J., Fischer, S., Koeberle, A., Schattel, V., Albrecht, W., Grütter, C., Werz, O., Rauh, D., Stehle, T., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.761 · Cited by 127
p38 MAP KINASE REGULATES TNF-α PRODUCTION IN HUMAN ASTROCYTES AND MICROGLIA BY MULTIPLE MECHANISMS
Lee, Y. B., Schrader, J. W., & Kim, S. U. (2000) · Cytokine · doi:10.1006/cyto.2000.0688 · Cited by 121
Cyclophilin D Deficiency Rescues Axonal Mitochondrial Transport in Alzheimer’s Neurons
Guo, L., Du, H., Yan, S., Wu, X., McKhann, G. M., Chen, J. X., & Yan, S. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054914 · Cited by 120
Rush, A. M., Wu, J., Rowan, M. J., & Anwyl, R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-14-06121.2002 · Cited by 118
Robinson, K. A., Stewart, C. A., Pye, Q. N., Nguyen, X. V., Kenney, L., Salzman, S., Floyd, R. A., & Hensley, K. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990315)55:6<724::aid-jnr7>3.0.co;2-9 · Cited by 117
Aouadi, M., Bost, F., Caron, L., Laurent, K., MARCHAND‐BRUSTEL, Y. L., & Binétruy, B. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0398 · Cited by 115
p38 MAP Kinase Inhibitors as Potential Therapeutic Drugs for Neural Diseases
Yasuda, S., Sugiura, H., Tanaka, H., Takigami, S., & Yamagata, K. (2011) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152411794961040 · Cited by 113
Toward the Treatment and Prevention of Alzheimer's Disease: Rational Strategies and Recent Progress
Gandy, S., & DeKosky, S. T. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-092611-084441 · Cited by 110
Modulation of h-Channels in Hippocampal Pyramidal Neurons by p38 Mitogen-Activated Protein Kinase
Poolos, N. P., Bullis, J. B., & Roth, M. K. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2069-06.2006 · Cited by 109
Hoozemans, J. J. M., & O’Banion, M. K. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007054038201 · Cited by 106
Hua, L. L., Zhao, M., Cosenza, M., Kim, M.-O., Huang, H., Tanowitz, H. B., Brosnan, C. F., & Lee, S. C. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00055-3 · Cited by 105
Xie, Y., Tan, Y., Zheng, Y., Du, X., & Liu, Q. (2017) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-017-1463-2 · Cited by 100
Mediators of tau phosphorylation in the pathogenesis of Alzheimer’s disease
Hanger, D. P., Seereeram, A., & Noble, W. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.104 · Cited by 98
Chen, X., Lin, R., Chang, L., Xu, S., Wei, X., Zhang, J., Wang, C., Anwyl, R., & Wang, Q. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.054 · Cited by 93
Zhong, P., Liu, W., Gu, Z., & Yan, Z. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.155143 · Cited by 91
Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer’s Disease
Liu‐Seifert, H., Initiative, T. A. D. N., Siemers, E., Price, K., Han, B., Selzler, K. J., Henley, D. B., Sundell, K. L., Aisen, P. S. S., Cummings, J. L., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142508 · Cited by 91
Zhang, H., Liu, Y., Lao, M., Ma, Z., & Yi, X. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.09.013 · Cited by 90
Zhang, Y., Mei, Z., Wu, J., & Wang, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801703200 · Cited by 90
p38 MAPK: A Potential Target of Chronic Pain
Lin, X., wang, M., Zhang, J., & Xu, R. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140915143040 · Cited by 90
Yoshida, H., & Goedert, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04052.x · Cited by 88
Wischik, C. M., & Staff, R. T. (2009) · The journal of nutrition health & aging · doi:10.1007/s12603-009-0046-5 · Cited by 86
Varnum, M. M., Kiyota, T., Dixie, K. L. I., Ikezu, S., & Ikezu, T. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.07.027 · Cited by 83
Physiological and Pathophysiological Implications of Synaptic Tau
Regan, P. L., Whitcomb, D. J., & Cho, K. (2016) · The Neuroscientist · doi:10.1177/1073858416633439 · Cited by 82
Watterson, D. M., Grum-Tokars, V. L., Roy, S. M., Schavocky, J. P., Bradaric, B. D., Bachstetter, A. D., Xing, B., Dimayuga, E., Saeed, F., Zhang, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066226 · Cited by 80
Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer’s disease
Chang, K., de Pablo, Y., Lee, H., Lee, H., Smith, M. A., & Shah, K. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06687.x · Cited by 79
Kinase activities increase during the development of tauopathy in htau mice
Kelleher, I., Garwood, C., Hanger, D. P., Anderton, B. H., & Noble, W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04930.x · Cited by 78
New Therapeutic Targets in Cardiology
Martin, E. D., Nicola, G. F. D., & Marber, M. S. (2012) · Circulation · doi:10.1161/circulationaha.111.071886 · Cited by 77
Floridoside suppresses pro-inflammatory responses by blocking MAPK signaling in activated microglia
Kim, M., Li, Y.-X., Dewapriya, P., Ryu, B., & Kim, S. (2013) · BMB Reports · doi:10.5483/bmbrep.2013.46.8.237 · Cited by 76
Izumi, Y., Tokuda, K., & Zorumski, C. F. (2007) · Hippocampus · doi:10.1002/hipo.20383 · Cited by 74
Peripheral expression of MAPK pathways in Alzheimer’s and Parkinson’s diseases
Wang, S., Zhang, C., Sheng, X., Zhang, X., Wang, B., & Zhang, G. (2014) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.08.017 · Cited by 72
Wang, Q., Rowan, M. J., & Anwyl, R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.004 · Cited by 70
Lee, M., McGeer, E. G., Kodela, R., Kashfi, K., & McGeer, P. L. (2013) · Glia · doi:10.1002/glia.22553 · Cited by 69
Astrocyte modulation of in vitro β‐amyloid neurotoxicity
Paradisi, S., Sacchetti, B., Balduzzi, M., Gaudi, S., & Malchiodi‐Albedi, F. (2004) · Glia · doi:10.1002/glia.20005 · Cited by 68
MohanaSundaram, A., Shanmugarajan, T. S., & Ravichandran, V. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9492-x · Cited by 65
Hu, W., Wang, G., Li, P., Wang, Y., Si, C., He, J. N., Long, W., Bai, Y., Feng, Z., & Wang, X. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.10.011 · Cited by 65
Ghasemi, R., Zarifkar, A., Rastegar, K., Maghsoudi, N., & Moosavi, M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.11.034 · Cited by 62
Anti-inflammatory effects of glaucocalyxin B in microglia cells
Gan, P., Li, Z., Chen, Y., Zhang, Y., Zhang, F., Zhou, X., Zhang, X., Gao, B., Zhen, X., Zhang, J., et al. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2015.04.005 · Cited by 57
Ashabi, G., Alamdary, S. Z., Ramin, M., & Khodagholi, F. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12000 · Cited by 52
The physiology and pathology of microtubule-associated protein tau
Wang, J., Gao, X., & Wang, Z.-H. (2014) · Essays in Biochemistry · doi:10.1042/bse0560111 · Cited by 49
Liu, C., Wu, Y., Zha, S., Liu, M., Wang, Y., Yang, G., Ma, K., Fei, Y., Zhang, Y., Hu, X., et al. (2015) · Brain Research · doi:10.1016/j.brainres.2015.11.040 · Cited by 49
Lei, H., Zhao, C., Liu, D.-M., Zhang, Y., Li, L., Wang, X., & Peng, Y. (2014) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2014.939586 · Cited by 46
Neurotropin® alleviates hippocampal neuron damage through a HIF ‐1α/ MAPK pathway
Fang, W., Zhao, D., Wang, F., Li, M., Fan, S., Liao, W., Zheng, Y., Liao, S., Xiao, S., Luan, P., et al. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12689 · Cited by 42
Liu, C., Ma, J., Liu, S., Zheng, G., Zhao-jun, F., & Sun, J.-M. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.07.033 · Cited by 41
Lee, Y. K., Choi, I. S., Ban, J. O., Lee, H. J., Lee, U. S., Han, S., Jung, J., Kim, Y. H., Kim, K. H., Oh, K., et al. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.04.002 · Cited by 41
Targeting the Hinge Glycine Flip and the Activation Loop: Novel Approach to Potent p38α Inhibitors
Martz, K. E., Dorn, A., Baur, B., Schattel, V., Goettert, M. I., Mayer‐Wrangowski, S. C., Rauh, D., & Laufer, S. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300951u · Cited by 41
Cui, Y., Wang, Q., Zhang, D., et al. (2016) · Current Alzheimer Research · doi:10.2174/156720501303160217122803 · Cited by 41
Chen, B., Teng, Y., Zhang, X., Lv, X., & Yin, Y. (2016) · BioMed Research International · doi:10.1155/2016/1421430 · Cited by 41
Ivanoiu, A., Pariente, J., Booth, K., Lobello, K., Luscan, G., Hua, L., Lucas, P., Styren, S. D., Yang, L., Li, D. X., et al. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0193-y · Cited by 40
Effect of Gender on Mitochondrial Toxicity of Alzheimer's A β Peptide
Viña, J., Lloret, A., Vallés, S. L., Borrás, C., Badía, M.-C., Pallardó, F. V., Sastre, J., & Alonso, M.-D. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1773 · Cited by 37
Fischer, S., Wentsch, H. K., Mayer‐Wrangowski, S. C., Zimmermann, M. O., Bauer, S. M., Storch, K., Nieß, R., Koeberle, S. C., Grütter, C., Boeckler, F. M., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301539x · Cited by 36
Koeberle, S. C., Fischer, S., Schollmeyer, D., Schattel, V., Grütter, C., Rauh, D., & Laufer, S. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300327h · Cited by 34
Esculentoside A suppresses Aβ1–42-induced neuroinflammation by down-regulating MAPKs pathwaysin vivo
Yang, H., Wang, S., Yu, L., Zhu, X., & Xu, Y. (2015) · Neurological Research · doi:10.1179/1743132815y.0000000066 · Cited by 33
Wentsch, H. K., Walter, N. M., Bührmann, M., Mayer‐Wrangowski, S. C., Rauh, D., Zaman, G. J. R., Willemsen‐Seegers, N., Buijsman, R. C., Henning, M., Dauch, D., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201701185 · Cited by 31
Xu, W., Li, Y., & Li, J. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.08.012 · Cited by 30
Baur, B., Storch, K., Martz, K. E., Goettert, M. I., Richters, A., Rauh, D., & Laufer, S. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401276h · Cited by 29
Li, W., Chu, Y., Zhang, L., Yin, L., & Li, L. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.08.028 · Cited by 28
Intraneuronally injected amyloid beta inhibits long-term potentiation in rat hippocampal slices
Nomura, I., Takechi, H., & Kato, N. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00589.2011 · Cited by 27
Suwanna, N., Thangnipon, W., & Soi‐ampornkul, R. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.06.029 · Cited by 26
A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors
Astolfi, A., Iraci, N., Manfroni, G., Barreca, M. L., & Cecchetti, V. (2015) · ChemMedChem · doi:10.1002/cmdc.201500030 · Cited by 26
Heo, J., Shin, H.-B., Lee, J. H., Kim, T., Inn, K., & Kim, N. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.06.036 · Cited by 25
Self-citationPierucci, F., Garcia‐Gil, M., Frati, A., Bini, F., Martinesi, M., Vannini, E., Mainardi, M., Luzzati, F., Peretto, P. M., Caleo, M., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.003 · Cited by 25
α-Iso-cubebene exerts neuroprotective effects in amyloid beta stimulated microglia activation
Park, S. Y., Park, S. J., Park, N. J., Joo, W. H., Lee, S.-J., & Choi, Y.-W. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.053 · Cited by 23
Ji, L., Zhao, X., Lu, W., Zhang, Q. H., & Hua, Z. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160322142226 · Cited by 23
Effects of Obovatol on GSH Depleted Glia-Mediated Neurotoxicity and Oxidative Damage
Lee, M., Kwon, B., Suk, K., McGeer, E. G., & McGeer, P. L. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9300-9 · Cited by 22
Hölttä, M., Dean, R. A., Siemers, E., Mawuenyega, K. G., Sigurdson, W. C., May, P. C., Holtzman, D. M., Portelius, E., Zetterberg, H., Bateman, R. J., et al. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0178-x · Cited by 21
Thangnipon, W., Puangmalai, N., Chinchalongporn, V., Jantrachotechatchawan, C., Kitiyanant, N., Soi‐ampornkul, R., Tuchinda, P., & Nobsathian, S. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.071 · Cited by 20
Interleukin-1 induces tau phosphorylation and morphological changes in cultured human astrocytes
Tanji, K., Mori, F., Imaizumi, T., Yoshida, H., Satoh, K., & Wakabayashi, K. (2003) · Neuroreport · doi:10.1097/00001756-200303030-00023 · Cited by 19
An overlooked neurotoxic species in Alzheimer's disease
Benilova, I., & Strooper, B. D. (2011) · Nature Neuroscience · doi:10.1038/nn.2871 · Cited by 15
Shen, J., Xu, L., Shan, L., Zhang, W., Li, H., & Wang, R. (2015) · Current Alzheimer Research · doi:10.2174/156720501209151019111244 · Cited by 11
Zou, L., Qin, H., He, Y., Huang, H., Lu, Y., & Chu, X. (2012) · PubMed Central · doi:10.3969/j.issn.1673-5374.2012.14.007 · Cited by 6
Cited by
Diversity and versatility of p38 kinase signalling in health and disease
Canovas, B., & Nebreda, A. R. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00322-w · Cited by 657
Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics
Thakur, S., Dhapola, R., Sarma, P., Medhi, B., & Reddy, D. H. (2023) · Inflammation · doi:10.1007/s10753-022-01721-1 · Cited by 557
Therapeutic Potential of Centella asiatica and Its Triterpenes: A Review
Sun, B., Wu, L., Wu, Y., Zhang, C., Qin, L., Hayashi, M., Kudo, M., Gao, M., & Liu, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.568032 · Cited by 353
Singh, S., & Singh, T. G. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200207120949 · Cited by 291
De Simone, A., Tumiatti, V., Andrisano, V., & Milelli, A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00931 · Cited by 110
Metadata
- Authors
- Lee, J. K., & Kim, N.-J.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2017-08-02
- Volume
- 22
- Issue
- 8
- Pages
- 1287
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2740079641
- Cited by
- 320
- References
- 163
- FWCI
- 17.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.